Olema Oncology to Participate in Upcoming Investor Conferences in June
28 May 2024 - 9:03PM
Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq:
OLMA), a clinical-stage biopharmaceutical company focused on the
discovery, development, and commercialization of targeted therapies
for women’s cancers, today announced that its management team will
participate in the following upcoming investor conferences:
Jefferies Global Healthcare
Conference Date: Wednesday, June 5, 2024, at 2:00
p.m. ET Location: Marriott Marquis in New York, NY Format: Fireside
Chat
Goldman Sachs 45th Annual
Global Healthcare Conference Date: Wednesday, June
12, 2024, at 11:20 a.m. ET Location: Loews Miami Beach Hotel in
Miami, FL Format: Fireside Chat
Live webcasts of the presentations and any accompanying
materials will be available under the News & Events section of
Olema’s investor relations website at ir.olema.com. The webcasts
will be archived for at least 30 days.
About Olema OncologyOlema Oncology is a
clinical-stage biopharmaceutical company committed to transforming
the standard of care and improving outcomes for women living with
cancer. Olema is advancing a pipeline of novel therapies by
leveraging our deep understanding of endocrine-driven cancers,
nuclear receptors, and mechanisms of acquired resistance. In
addition to our lead product candidate, palazestrant (OP-1250), a
proprietary, orally-available complete estrogen receptor (ER)
antagonist (CERAN) and a selective ER degrader (SERD), Olema is
developing a potent KAT6 inhibitor (OP-3136). Olema is
headquartered in San Francisco and has operations in Cambridge,
Massachusetts. For more information, please visit us at
www.olema.com.
Contact:Geoffrey Mogilner, Vice President, Investor Relations
and Communicationsir@olema.com
Olema Pharmaceuticals (NASDAQ:OLMA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Olema Pharmaceuticals (NASDAQ:OLMA)
Historical Stock Chart
From Sep 2023 to Sep 2024